Anavex Life Sciences Corp. SEC filings AVXL
Anavex Life Sciences Corp. has 634 filings in SEC EDGAR's recent list, going back to Jan 13, 2005. Its latest annual report, Form 10-K, was filed on Nov 25, 2025 for the period ended Sep 30, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 28, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (officer or director change). The company's fiscal year ends on September 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Jul 25, 2025 | — |
| S-3 | Shelf registration | Jul 14, 2025 | — |
| S-3 | Shelf registration | Jul 29, 2024 | — |
| 424B5 | Prospectus supplement | Feb 7, 2023 | — |
| S-8 | Employee stock plan registration | Jun 10, 2022 | — |
| S-3ASR | Automatic shelf registration | Sep 24, 2021 | — |
| 424B5 | Prospectus supplement | Jun 24, 2021 | — |
| S-8 | Employee stock plan registration | Apr 9, 2021 | — |
| 424B5 | Prospectus supplement | Feb 16, 2021 | — |
| 424B5 | Prospectus supplement | Jul 2, 2020 | — |
| 424B5 | Prospectus supplement | May 1, 2020 | — |
| 424B5 | Prospectus supplement | May 1, 2020 | — |
| POS AM | Form pos am | Sep 17, 2019 | — |
| 424B5 | Prospectus supplement | Sep 13, 2019 | — |
| S-3/A | Amendment no. 4 to form s-3 | Sep 13, 2019 | — |
| S-3 | Shelf registration | Jul 3, 2019 | — |
| 424B5 | Prospectus supplement | Jun 12, 2019 | — |
| 424B5 | Prospectus supplement | Mar 18, 2019 | — |
| 424B5 | Prospectus supplement | Jul 6, 2018 | — |
| 424B3 | Prospectus | Sep 7, 2017 | — |
| S-8 | Employee stock plan registration | Aug 11, 2017 | — |
| S-3 | Shelf registration | May 26, 2017 | — |
| 424B3 | Prospectus | Sep 12, 2016 | — |
| S-3/A | Filing | Aug 31, 2016 | — |
| S-3/A | Filing | Aug 26, 2016 | — |
| S-3/A | Filing | Aug 18, 2016 | — |
| S-3 | Shelf registration | Oct 26, 2015 | — |
| 424B3 | Prospectus | Jul 8, 2015 | — |
| POS AM | Form pos am | Jun 19, 2015 | — |
| 424B3 | Prospectus | Mar 25, 2015 | — |
| S-1 | Registration statement | Mar 5, 2015 | — |
| POS AM | Form pos am | Aug 6, 2014 | — |
| 424B3 | Prospectus | Jul 24, 2014 | — |
| S-1/A | Amended registration statement | Jul 10, 2014 | — |
| S-1 | Registration statement | Apr 11, 2014 | — |
| 424B3 | Prospectus | Oct 29, 2013 | — |
| 424B3 | Prospectus | Oct 18, 2013 | — |
| S-1 | Registration statement | Oct 10, 2013 | — |
| S-1/A | Amended registration statement | Sep 25, 2013 | — |
| S-1/A | Amended registration statement | Sep 24, 2013 | — |
| S-1 | Registration statement | Sep 4, 2013 | — |
| F-8/A | Filing | Nov 15, 2005 | — |
Showing 42 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- AVXL (Nasdaq)
- Fiscal year ends
- September 30
- Headquarters
- New York, NY
- SEC filer status
- Large accelerated filer, Smaller reporting company
- SEC CIK
- 1314052
- Former names
- Thrifty Printing Inc. (until Jan 25, 2007)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.